Mangoceuticals Inc. (MGRX)
Mangoceuticals Statistics
Share Statistics
Mangoceuticals has 5.17M shares outstanding. The number of shares has increased by -79.17% in one year.
| Shares Outstanding | 5.17M |
| Shares Change (YoY) | -79.17% |
| Shares Change (QoQ) | 107.87% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.87M |
| Failed to Deliver (FTD) Shares | 2.95K |
| FTD / Avg. Volume | 1.84% |
Short Selling Information
The latest short interest is 194.4K, so 7.82% of the outstanding shares have been sold short.
| Short Interest | 194.4K |
| Short % of Shares Out | 7.82% |
| Short % of Float | 15.89% |
| Short Ratio (days to cover) | 0.21 |
Valuation Ratios
The PE ratio is -0.55 and the forward PE ratio is null. Mangoceuticals's PEG ratio is 0.01.
| PE Ratio | -0.55 |
| Forward PE | n/a |
| PS Ratio | 10.12 |
| Forward PS | 618.7 |
| PB Ratio | 0.34 |
| P/FCF Ratio | -0.98 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mangoceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.05 |
| Quick Ratio | 0.05 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.04 |
| Interest Coverage | -581.9 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $157.75K |
| Profits Per Employee | $-2.9M |
| Employee Count | 3 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -33.54% in the last 52 weeks. The beta is 1.51, so Mangoceuticals's price volatility has been higher than the market average.
| Beta | 1.51 |
| 52-Week Price Change | -33.54% |
| 50-Day Moving Average | 3.77 |
| 200-Day Moving Average | 3.69 |
| Relative Strength Index (RSI) | 34.43 |
| Average Volume (20 Days) | 160.62K |
Income Statement
In the last 12 months, Mangoceuticals had revenue of 473.26K and earned -8.71M in profits. Earnings per share was -4.4.
| Revenue | 473.26K |
| Gross Profit | 237.35K |
| Operating Income | -7.97M |
| Net Income | -8.71M |
| EBITDA | -7.96M |
| EBIT | -8.69M |
| Earnings Per Share (EPS) | -4.4 |
Balance Sheet
The company has 58.65K in cash and 214.96K in debt, giving a net cash position of -156.31K.
| Cash & Cash Equivalents | 58.65K |
| Total Debt | 214.96K |
| Net Cash | -156.31K |
| Retained Earnings | -20.81M |
| Total Assets | 15.37M |
| Working Capital | -1.35M |
Cash Flow
In the last 12 months, operating cash flow was -4.86M and capital expenditures 0, giving a free cash flow of -4.86M.
| Operating Cash Flow | -4.86M |
| Capital Expenditures | 0 |
| Free Cash Flow | -4.86M |
| FCF Per Share | -2.46 |
Margins
Gross margin is 50.15%, with operating and profit margins of -1684.48% and -1839.61%.
| Gross Margin | 50.15% |
| Operating Margin | -1684.48% |
| Pretax Margin | -1839.84% |
| Profit Margin | -1839.61% |
| EBITDA Margin | -1682.39% |
| EBIT Margin | -1684.48% |
| FCF Margin | -1027.72% |
Dividends & Yields
MGRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for MGRX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Oct 16, 2024. It was a backward split with a ratio of 1:15.
| Last Split Date | Oct 16, 2024 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | 0.42 |
| Piotroski F-Score | 3 |